Bioinformatics Research and Applications: 20th International Symposium, ISBRA 2024, Kunming, China, July 1921, 2024, Proceedings, Part III | Agenda Bookshop Skip to content
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Pavel Skums
B01=Wei Peng
B01=Zhipeng Cai
Category1=Non-Fiction
Category=PS
Category=UK
Category=UYM
Category=UYQ
COP=Singapore
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€50 to €100
PS=Active
softlaunch

Bioinformatics Research and Applications: 20th International Symposium, ISBRA 2024, Kunming, China, July 1921, 2024, Proceedings, Part III

English

This book constitutes the refereed proceedings of the 20th International Symposium on Bioinformatics Research and Applications, ISBRA 2024, held in Kunming, China, in July 1921, 2024.

The 93 full papers  included in this book were carefully reviewed and selected from 236 submissions. The symposium provides a forum for the exchange of ideas and results among researchers, developers, and practitioners working on all aspects of bioinformatics and computational biology and their applications.

See more
Current price €53.19
Original price €55.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Pavel SkumsB01=Wei PengB01=Zhipeng CaiCategory1=Non-FictionCategory=PSCategory=UKCategory=UYMCategory=UYQCOP=SingaporeDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€50 to €100PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Dimensions: 155 x 235mm
  • Publication Date: 10 Jul 2024
  • Publisher: Springer Verlag Singapore
  • Publication City/Country: Singapore
  • Language: English
  • ISBN13: 9789819750863

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept